SBIR/STTR Research Award
PHASE I WILL INVOLVE ASCERTAINING THE FEASIBILITY OF A NOVEL ELECTROCHEMICAL IMMUNOSENSOR APPROACH.
Award amount
$49,951Program and phase
SBIR · Phase IAward year
1985Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- SERACARE LIFE SCIENCES, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
PHASE I WILL INVOLVE ASCERTAINING THE FEASIBILITY OF A NOVEL ELECTROCHEMICAL IMMUNOSENSOR APPROACH. ELECTRODES IN SERIES AND WITH ELECTROACTIVE REAGENTS WILL BE CONSTRUCTED AND EVALUATED FOR THEIR ABILITY TO DETECT HAPTENS AND ANTIGENS SUCH AS AFLATOXIN B1 AND HTLV-III. AN ELECTROCHEMICAL IMMUNOSENSOR OR ANTIBODY ELECTRODE THAT IS FAST, RELIABLE, AND SENSITIVE WILL HAVE MANY VALUABLE COMMERCIAL APPLICATIONS IN THE FIELDS OF CLINICAL CHEMISTRY, BIOTECHNOLOGY, THE FOOD INDUSTRY, AND OTHER COMMERCIAL AND RESEARCH FIELDS. PHASE II WILL INVOLVE THE DEVELOPMENT OF A PROTOTYPE ELECTRODE FOR COMMERCIALIZATION.
Technology keywords
Not reported